Observational Study of the Safety and Efficacy of Norditropin® in Patients With SGA (Small for Gestational Age) Short Stature That Are Still Growing

A Multicentre, Open Label, Observational, Non-interventional Study to Evaluate on Long-term Safety and Efficacy of Norditropin® Formulation in Patients With SGA Short Stature Without Closure of Epiphyseal Discs

This study is conducted in Japan. The aim of this observational study is to collect information about the safety and efficacy of Norditropin® in the long-term treatment of patients with a SGA (small for gestational age) short stature where the growth plate in the long bones (epiphyseal disc) is not closed. An extension to the GHLIQUID-1517 trial (NCT00184717).

Inclusion Criteria:

• Participation in the GHLIQUID-1517 trial
• Patients with SGA (small for gestational age) short stature that are still growing

Exclusion Criteria:

• Known or suspected allergy to study product(s) or related products
• Diabetes Mellitus
• Patients with malignant tumor(s)
• Pregnant or likely to get pregnant